A University of Oxford study published recently has revealed that the risk of rare blood clots following the COVID-19 infection is nearly 100-fold higher than normal, and several-fold higher than it is following vaccination or following influenza.

According to the research, the rare blood clotting, called cerebral venous thrombosis (CVT), was more commonly seen after COVID-19 infection, than in any of the comparison groups, with 30% of these cases observed in those below 30 years of age. In comparison with the COVID-19 vaccines being administered at present, this risk is 8-10 times higher, and compared to the baseline, nearly 100 times higher reported the study. The study authors thus concluded that COVID-19 heightens the risk of CVT to a considerable extent. Additionally, the COVID-19 risk is higher than that seen with the current vaccines… (NDTV – PTI, April 16, 2021)